First Time Loading...

China Resources Medical Holdings Company Ltd
HKEX:1515

Watchlist Manager
China Resources Medical Holdings Company Ltd Logo
China Resources Medical Holdings Company Ltd
HKEX:1515
Watchlist
Price: 4.43 HKD 1.61% Market Closed
Updated: May 14, 2024

EV/EBITDA
Enterprise Value to EBITDA

1.2
Current
4.5
Median
12.9
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
1.2
=
Enterprise Value
2.2B
/
EBITDA
1.6B
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
1.1
2-Years Forward
EV/EBITDA
1
3-Years Forward
EV/EBITDA
1.1

See Also

Discover More